Q3 FY2026
Filed Nov 9, 2026Baldwin Q3 2026: total revenue up 31% to $480.3 million, organic growth 6%, GAAP net loss of $81.6 million, adjusted diluted EPS $0.42 (up 35%); take-private at $32.50 per share pending
Reported revenue growth and the non-GAAP measures (adjusted EBITDA, adjusted net income, adjusted diluted EPS, adjusted free cash flow) all rose year over year, but organic growth was 6% for the quarter and 3% for nine months, GAAP net loss widened sharply to $(81,642) thousand, and the shares are subject to an all-cash take-private at $32.50 per share.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Q3 2026 Total revenuesGAAP | $480.3M | – | 31% |
| Q3 2026 Commissions and feesGAAP | $475.5M | – | – |
| Q3 2026 Investment incomeGAAP | $4.74M | – | – |
| Q3 2026 Colleague compensation and benefitsGAAP | $255.8M | – | – |
| Q3 2026 Outside commissionsGAAP | $79.75M | – | – |
| Q3 2026 Other operating expensesGAAP | $111.4M | – | – |
| Q3 2026 Amortization expenseGAAP | $56.42M | – | – |
| Q3 2026 Change in fair value of contingent considerationGAAP | $17.60M | – | – |
| Q3 2026 Depreciation expenseGAAP | $2.45M | – | – |
| Q3 2026 Total operating expensesGAAP | $523.5M | – | – |
| Q3 2026 Operating income (loss)GAAP | −$43.21M | – | – |
| Q3 2026 Interest expense, netGAAP | −$42.89M | – | – |
| Q3 2026 Net lossGAAP | −$81.64M | – | – |
| Q3 2026 Net loss marginGAAP | (17)% | – | – |
| Q3 2026 Net loss attributable to BaldwinGAAP | −$58.12M | – | – |
| Q3 2026 Basic and diluted loss per shareGAAP | $(0.63) | – | – |
| Q3 2026 Adjusted EBITDAnon-GAAP | $106.9M | – | 47% |
| Q3 2026 Adjusted EBITDA marginnon-GAAP | 22.2% | – | – |
| Q3 2026 Adjusted net incomenon-GAAP | $59.41M | – | – |
| Q3 2026 Adjusted diluted EPSnon-GAAP | $0.42 | – | 35% |
| Q3 2026 Organic revenuenon-GAAP | $383.8M | – | – |
| Q3 2026 Organic revenue growthnon-GAAP | 6% | – | 6% |
| Q3 2026 Net cash provided by operating activitiesGAAP | $54.19M | – | – |
| Q3 2026 Adjusted free cash flownon-GAAP | $55.55M | – | 33% |
| Nine months 2026 Total revenuesGAAP | $1.51B | – | 30% |
| Nine months 2026 Commissions and feesGAAP | $1.49B | – | – |
| Nine months 2026 Colleague compensation and benefitsGAAP | $803.8M | – | – |
| Nine months 2026 Outside commissionsGAAP | $218.2M | – | – |
| Nine months 2026 Other operating expensesGAAP | $429.6M | – | – |
| Nine months 2026 Amortization expenseGAAP | $167.5M | – | – |
| Nine months 2026 Total operating expensesGAAP | $1.66B | – | – |
| Nine months 2026 Operating income (loss)GAAP | −$152.8M | – | – |
| Nine months 2026 Interest expense, netGAAP | −$127.5M | – | – |
| Nine months 2026 Net lossGAAP | −$139.5M | – | – |
| Nine months 2026 Net loss marginGAAP | (9)% | – | – |
| Nine months 2026 Net loss attributable to BaldwinGAAP | −$94.78M | – | – |
| Nine months 2026 Basic and diluted loss per shareGAAP | $(1.02) | – | – |
| Nine months 2026 Adjusted EBITDAnon-GAAP | $360.8M | – | 33% |
| Nine months 2026 Adjusted EBITDA marginnon-GAAP | 24.0% | – | – |
| Nine months 2026 Adjusted net incomenon-GAAP | $217.2M | – | – |
| Nine months 2026 Adjusted diluted EPSnon-GAAP | $1.53 | – | 12% |
| Nine months 2026 Organic revenuenon-GAAP | $1.18B | – | – |
| Nine months 2026 Organic revenue growthnon-GAAP | 3% | – | 3% |
| Nine months 2026 Net cash provided by (used in) operating activitiesGAAP | $93.68M | – | – |
| Nine months 2026 Adjusted free cash flownon-GAAP | $101.8M | – | 33% |
Capital returns
- Nine months 2026 Repurchase of common stock: $(126,833) thousand (cash flow statement); the nine months 2025 column prints a dash (nil).
- Class A common stock issued and outstanding rose from 71,779,608 shares at December 31, 2025 to 97,931,534 shares at September 30, 2026; Class B shares fell from 46,703,818 to 42,274,762 over the same dates (balance sheet share counts).
What drove it
- Partnership commissions and fees, as reconciled in the organic revenue table, were $91,690 thousand in Q3 2026 versus $12,222 thousand in Q3 2025, and $309,930 thousand in nine months 2026 versus $14,202 thousand in nine months 2025.
- The release defines CAC Group as the business of Cobbs Allen Capital Holdings, LLC, acquired by Baldwin effective January 1, 2026, and reports CAC Group total revenue growth of 14% for Q3 and 20% for nine months 2026, calculated on standalone CAC Group GAAP revenue.
- Other operating expenses rose to $111,424 thousand in Q3 2026 from $56,008 thousand, and the Other addbacks line in the adjusted EBITDA reconciliation was $14,372 thousand versus $3,286 thousand.
- Adjusted EBITDA margin was 22.2% in Q3 2026 versus 19.8%, a 240 basis point expansion as stated in the release.
Concerns
- GAAP net loss was $(81,642) thousand in Q3 2026 versus $(30,237) thousand, and an operating loss of $(43,209) thousand replaced operating income of $3,216 thousand in Q3 2025.
- Organic revenue growth was 6% for Q3 2026 and 3% for nine months 2026, against total revenue growth of 31% and 30%.
- Go-Private Transaction costs of $21,003 thousand were excluded from adjusted metrics in Q3 2026 and were recorded in the adjusted EBITDA reconciliation.
- Income tax line: the release prints a benefit of $(147,015) thousand for nine months 2026 against an expense of 685 thousand in nine months 2025, and the nine-month GAAP net loss attributable to Baldwin is $(94,775) thousand.
- Contingent consideration fair value change was $17,598 thousand in Q3 2026 versus $1,980 thousand, and the current portion of contingent earnout liabilities rose to $248,824 thousand from $9,004 thousand at year-end 2025.
- Interest expense, net was $(42,892) thousand in Q3 2026 versus $(31,132) thousand.
What to watch
- Closing of the take-private by Sequence AI Holdings, Inc. and DFO Management, LLC at $32.50 per share in cash, expected in the first quarter of 2027, subject to stockholder approval, regulatory approvals and other closing conditions.
- Organic revenue growth, which was 6% in Q3 2026 and 3% for nine months 2026, relative to reported total revenue growth.
- The gap between GAAP net loss and adjusted net income, including amortization, contingent consideration changes and transaction costs.
- Adjusted free cash flow and the level of contingent earnout payments and cash consideration for business combinations.
- Level of revolver usage and long-term debt following the nine-month increase in both lines.
Balance sheet and cash flow
- Cash and cash equivalents: $188,616 thousand at September 30, 2026 versus $123,669 thousand at December 31, 2025 (balance sheet, not a same-period prior-year comparison).
- Borrowing capacity under the revolving credit facility: $289.1 million as of September 30, 2026 (release text).
- Revolving line of credit: $272,000 thousand at September 30, 2026 versus $107,000 thousand at December 31, 2025.
- Long-term debt, less current portion: $2,148,036 thousand at September 30, 2026 versus $1,566,122 thousand at December 31, 2025.
- Current portion of contingent earnout liabilities: $248,824 thousand at September 30, 2026 versus $9,004 thousand at December 31, 2025.
- Total assets: $5,942,403 thousand at September 30, 2026 versus $3,862,220 thousand at December 31, 2025.
- Total stockholders' equity: $1,352,901 thousand at September 30, 2026 versus $1,083,879 thousand at December 31, 2025.
- Nine months 2026 cash consideration paid for business combinations, net of cash received: $(447,503) thousand versus $(85,511) thousand in nine months 2025.
- Nine months 2026 capital expenditures: $(42,886) thousand versus $(29,174) thousand in nine months 2025.
- Nine months 2026 proceeds from refinancing of long-term debt: $600,000 thousand versus $1,941,921 thousand in nine months 2025.
- Cash and cash equivalents and fiduciary cash at end of nine months 2026: $575,950 thousand versus $325,944 thousand at end of nine months 2025.
Analysis
Baldwin reported third quarter 2026 total revenues of $480,264 thousand, up 31% from $365,389 thousand, while organic revenue growth was 6% and organic revenue was $383,835 thousand against $350,095 thousand. The release attributes the gap between total and organic growth to acquisitions, and the organic revenue table shows partnership commissions and fees of $91,690 thousand in the quarter against $12,222 thousand a year earlier. Revenue growth was therefore concentrated in acquired partnerships, including the CAC Group, which the release reports grew total revenue 14% in the quarter and 20% for nine months.
Costs rose faster than revenue on a GAAP basis. Colleague compensation and benefits were $255,834 thousand against $193,031 thousand, other operating expenses were $111,424 thousand against $56,008 thousand, and amortization expense was $56,420 thousand against $30,394 thousand. Total operating expenses were $523,473 thousand, producing an operating loss of $(43,209) thousand against operating income of $3,216 thousand a year earlier. Net loss was $(81,642) thousand, or a net loss margin of (17)%, and the basic and diluted loss per share was $(0.63) against $(0.27).
On the company's non-GAAP measures, adjusted EBITDA rose 47% to $106,857 thousand, with a margin of 22.2% against 19.8%, and adjusted diluted EPS was $0.42 against $0.31, up 35% as printed. The reconciliation adds back amortization, share-based compensation, a $21,003 thousand Go-Private Transaction cost line and a $17,598 thousand change in fair value of contingent consideration, among other items. Investors comparing the two sets of figures should weigh the size of these adjustments, which total far more than the difference between the GAAP and non-GAAP per share figures.
Cash generation was stronger than earnings. Net cash provided by operating activities was $54,194 thousand in Q3 2026 against $41,017 thousand, and adjusted free cash flow rose to $55,553 thousand from $41,810 thousand. For nine months, operating cash flow was $93,680 thousand against $(39,687) thousand. Cash consideration for business combinations was $(447,503) thousand over the nine months, and the revolving line of credit rose to $272,000 thousand from $107,000 thousand at year-end 2025, while long-term debt increased to $2,148,036 thousand from $1,566,122 thousand. The company reports $188,616 thousand of cash and $289.1 million of revolver borrowing capacity at quarter end.
The filing contains no revenue, margin or earnings guidance and no outlook section, so no forward figures can be compared with prior expectations. The dominant forward item is the September 14, 2026 merger agreement under which the stockholders would receive $32.50 per share in cash, with closing expected in the first quarter of 2027. Results should therefore be read as those of a company that is being taken private, with the release providing no operating outlook for the period after closing.
Not in the filing
stated, not guessed- Company guidance for revenue, gross margin, operating expenses or tax rate: the filing contains no outlook section.
- Prior-year and prior-quarter comparisons for commissions and fees, investment income and most expense lines: the release does not print percentage changes for them.
- Prior-quarter (Q2 2026) figures: the release compares only with the prior-year periods.
- Segment revenue breakdown: the filing does not split revenue by segment, business or geography; CAC Group is reported only as a growth rate.
- Organic revenue growth prior-period figure: the table prints 5% in the 2025 column without a clear 2025 base; it is not used as a prior-year figure for Q3 2026 growth.
- Executive quotes: the release contains no management commentary or named speaker remarks.
- Gross margin: the filing does not print a gross margin figure.
- Share price reaction and analyst consensus: not contained in the filing and not provided.
- Prior-year and prior-quarter comparisons for cash and debt balances: balance sheet lines are compared with December 31, 2025, not with the same period of the prior year.
- Adjusted free cash flow and adjusted EBITDA percentage changes for Q3 and nine months, except those printed in the release text (47%, 33%, 35%, 12%).
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.